Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeuticsastex_logo_s_tag_otsuka-group_pms_v4 with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutica
l Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide.
For more information about Astex Pharmaceuticals, please visit